Presidio Management Group X LLC - Nov 9, 2021 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
10%+ Owner
Signature
Dale Holladay, Attorney in Fact for each Reporting Person
Stock symbol
EFTR
Transactions as of
Nov 9, 2021
Transactions value $
-$917,006
Form type
4
Date filed
11/12/2021, 04:52 PM
Previous filing
Aug 27, 2021
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Sale -$307K -27.9K -0.6% $11.00* 4.64M Nov 9, 2021 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$9.83K -893 -0.6% $11.00* 149K Nov 9, 2021 Directly owned by AFF X F1, F2
transaction EFTR Common Stock Sale -$344K -32.9K -0.71% $10.44* 4.61M Nov 10, 2021 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$11K -1.05K -0.71% $10.44* 148K Nov 10, 2021 Directly owned by AFF X F1, F2
transaction EFTR Common Stock Sale -$121K -11.6K -0.25% $10.37* 4.6M Nov 11, 2021 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$3.87K -373 -0.25% $10.37* 147K Nov 11, 2021 Directly owned by AFF X F1, F2
transaction EFTR Common Stock Sale -$117K -11.6K -0.25% $10.07* 4.59M Nov 12, 2021 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$3.75K -372 -0.25% $10.07* 147K Nov 12, 2021 Directly owned by AFF X F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.57 to $11.82, inclusive for sales on 11/9/21; prices ranging from $10.22 to $10.72, inclusive for sales on 11/10/21; prices ranging from $10.16 to $10.56, inclusive for sales on 11/11/21; and prices ranging from $10.00 to $10.22, inclusive for sales on 11/12/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4
F2 Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.